Elevance Health announced management changes designed to simplify decision-making and strengthen execution across its Carelon and Health Benefits segments. Peter D. Haytaian will transition from his role as Executive Vice President and President of Carelon, effective May 4, 2026, due to family commitments. He will serve as a Special Advisor through December 31, 2026, to ensure a smooth transition. Mark Kaye, Executive Vice President and Chief Financial Officer, will expand his responsibilities to include oversight of Carelon, the company's healthcare services operations. Felicia Norwood, Executive Vice President and Chief Health Benefits Officer, will lead the consolidated Health Benefits organization, bringing together major Health Benefits businesses and core operating functions. The company reaffirmed its full-year 2026 guidance for shareholders earnings to be at least $22.30 per diluted share, including approximately $3.20 per diluted share of net unfavorable items. Excluding these items, the company continues to expect adjusted shareholders earnings to be at least $25.50 per diluted share. The full-year 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points was also reaffirmed.